Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2026-02-12 00:00:00 ET · period of report 2026-02-10 · accession 0001193125-26-048881 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-12 | 2026-02-10 | PHAT | Cook Anne Marie | Chief Legal Off, Corp. Sec | A - Grant | $0.00 | +3,461 | 90.2K | +4% | $0 | |
| 2026-02-12 | 2026-02-10 | PHAT | Cook Anne Marie | Chief Legal Off, Corp. Sec | F - Tax | $12.82 | -1,535 | 88.7K | -2% | -$19.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-10 | A | A | 3,461 | $0.00 | 90,195 | D | — | — | (F1) Represents shares issued upon vesting of performance stock units granted to the reporting person on June 23, 2025 based on the achievement of performance criteria determined to be satisfied on February 10, 2026. (F2) Includes 1,722 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in January 2026. |
| 2 | Common | Common Stock | 2026-02-10 | F | D | 1,535 | $12.82 | 88,660 | D | — | — |